EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Structure and function of MDM2 and MDM4 in health and disease

Ivy Yiyi Zhu iD, Alec Lloyd, William R Critchley iD, Queen Saikia iD, Dhananjay Jade iD, Aysha Divan, Elton Zeqiraj iD, Michael A Harrison iD, Christopher J Brown, Sreenivasan Ponnambalam iD

Biochemical Journal · 2025

DOI: 10.1042/bcj20240757 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemical Journal, 2025. Verfasst von Ivy Yiyi Zhu und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Molecular and Cellular Biology, University of Leeds, Leeds LS2 9JT, U.K. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-mdm2, Proto-Oncogene Proteins, Neoplasms, Nuclear Proteins. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Both mouse double-minute 2 (MDM2), an E3 ubiquitin ligase, and its closely related paralog, MDM4, which lacks E3 activity, play central roles in cellular homeostasis. MDM-linked dysfunction is associated with an increased risk of oncogenesis, primarily through targeting the tumor suppressor protein p53 for ubiquitination and degradation. Recent studies have revealed multifaceted roles of MDM proteins that are p53 independent with implications for their oncogenic properties. This review aims to provide an overview of MDM2 and MDM4, by assessing gene and protein structure and implications for protein–protein interactions and functions in cell and animal physiology. We also explore MDM2 and MDM4 role(s) in angiogenesis, a critical feature of solid tumor growth and progression. Finally, we discuss the current landscape in the development of MDM2 and MDM4 inhibitors for cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-mdm2Proto-Oncogene ProteinsNeoplasmsNuclear ProteinsHumansAnimalsCell Cycle ProteinsTumor Suppressor Protein p53UbiquitinationNeovascularization, Pathologic

Stichwörter der Autor:innen

26S proteasomeE3 ubiquitin ligaseMDM2MDM4cancerp53

Substanzen

Proto-Oncogene Proteins c-mdm2Proto-Oncogene ProteinsMDM4 protein, humanCell Cycle ProteinsTumor Suppressor Protein p53Nuclear ProteinsMDM2 protein, human

Autor:innen und Institutionen

  • School of Molecular and Cellular Biology, University of Leeds, Leeds LS2 9JT, U.K.
  • School of Biomedical Sciences, University of Leeds, Leeds LS2 9JT, U.K.
  • Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore.

ORCID-Profile: Ivy Yiyi Zhu, William R Critchley, Queen Saikia, Dhananjay Jade, Elton Zeqiraj, Michael A Harrison, Sreenivasan Ponnambalam

Förderung

  • Wellcome Trust

Zitieren

APA

Zhu, I. Y., Lloyd, A., Critchley, W. R., Saikia, Q., Jade, D., Divan, A., Zeqiraj, E., Harrison, M. A., Brown, C. J., & Ponnambalam, S. (2025). Structure and function of MDM2 and MDM4 in health and disease. Biochemical Journal. https://doi.org/10.1042/bcj20240757

Vancouver

Zhu IY, Lloyd A, Critchley WR, Saikia Q, Jade D, Divan A, et al. Structure and function of MDM2 and MDM4 in health and disease. Biochemical Journal. 2025. doi:10.1042/bcj20240757

BibTeX
@article{Zhu2025,
  author = {Zhu, Ivy Yiyi and Lloyd, Alec and Critchley, William R and Saikia, Queen and Jade, Dhananjay and Divan, Aysha and Zeqiraj, Elton and Harrison, Michael A and Brown, Christopher J and Ponnambalam, Sreenivasan},
  title = {Structure and function of MDM2 and MDM4 in health and disease},
  journal = {Biochemical Journal},
  year = {2025},
  doi = {10.1042/bcj20240757}
}
Kostenlos starten →